Avadim Holdings, Inc Secures Innovative Technology Contract from Vizient for Theraworx Protect

Avadim Holdings, Inc has announced that its product, Theraworx Protect, has been awarded an Innovative Technology contract from Vizient, Inc, the nation's largest provider-driven healthcare performance improvement company. The contract, based on recommendations from hospital experts on Vizient's customer-led councils, signifies that Theraworx Protect has unique qualities that could significantly improve the healthcare industry.

Innovative Technology contracts are issued following a thorough review and interaction with products submitted through Vizient's Innovative Technology Program. These contracts are recommended by Vizient's customer-led councils, which identify technologies with the potential to enhance clinical care, improve patient and healthcare worker safety, or boost the operational efficiency of healthcare organizations.

Keith Daniels, CEO of Avadim Health, expressed his enthusiasm for the recognition, stating, 'We are very excited to have Theraworx Protect receive a Vizient Innovative Technology contract. Helping healthcare providers care for patients is important work, and we are eager to demonstrate how Theraworx Protect can help impact the delivery of care.'

Theraworx Protect is an Advanced Hygiene and Barrier system that serves as a non-inferior alternative to CHG bathing in various healthcare settings, including adult and pediatric ICUs, critical care units, pre-surgical applications, and for patients with indwelling catheters. It is a trusted component in infection control bundles for central line-associated bloodstream infections, catheter-associated urinary tract infections, and surgical site infections. The product's low pH formulation supports acidic pH, surfactant, preservative, and barrier systems, which are essential for maintaining skin function and integrity while creating a hostile environment for pathogens.

According to a study published in the American Journal of Infection Control, Theraworx Protect has been shown to be a safe and effective alternative to traditional antiseptic products like Chlorhexidine gluconate, which have limitations in patient use.

Kelly Flaharty, senior director of contract services at Vizient, highlighted the importance of the Innovative Technology Exchange, stating, 'The Innovative Technology Exchange fosters a unique opportunity for healthcare providers to interact with products and services that have the potential to impact the healthcare industry and improve clinical care or business models of organizations. We are pleased to invite Avadim Holdings, Inc to the Exchange.'

Vizient represents a diverse array of healthcare providers, including academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute care providers. With an annual purchasing volume exceeding $140 billion, Vizient's Innovative Technology Program works with customer-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. The program can award contracts to products deemed worthy of the Innovative Technology designation outside the competitive bid cycle.

Avadim Holdings, Inc, based in Swannanoa, North Carolina, is dedicated to identifying gaps in care and addressing them with innovative and accessible healthcare solutions. Their Theraworx brand offers a wide range of total-body solutions, from advanced hygiene to pain relief, aiming to transform health and wellness.